Lobe Sciences
Tracked across 2 events · 14 articles · First seen Apr 11, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Lobe Sciences announced and closed a non-brokered private placement, raising approximately $950,000 for working capital, general corporate purposes, and to advance its S-100 drug candidate.
Apr 11, 2026 · 7 articles
Business
Impact: Lobe Sciences is the issuer and primary beneficiary of the private placement, raising $2.1 million to fund operations and clinical development. The capital infusion supports its S-100 program and working capital needs.
Aug 12, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Lobe Sciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard